{"id":563848,"date":"2026-09-22T12:30:00","date_gmt":"2026-09-22T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=563848"},"modified":"2026-09-22T13:06:03","modified_gmt":"2026-09-22T11:06:03","slug":"bloqueo-de-la-interleucina-o-inhibicion-de-ox40-l","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/bloqueo-de-la-interleucina-o-inhibicion-de-ox40-l\/","title":{"rendered":"\u00bfBloqueo de la interleucina o inhibici\u00f3n de OX40-(L)?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>En la patog\u00e9nesis de la dermatitis at\u00f3pica (DA) interviene una compleja cascada que se desarrolla a distintos niveles. Para el tratamiento de la DA de gravedad moderada a grave se han desarrollado terapias con anticuerpos inmunomoduladores que intervienen de diversas maneras en el proceso inflamatorio. Adem\u00e1s de los f\u00e1rmacos biol\u00f3gicos dirigidos contra el receptor de la interleucina(IL)-31-R-\u03b1, IL-4R-\u03b1 o, de forma selectiva, contra la IL-13, actualmente se est\u00e1n investigando en ensayos cl\u00ednicos los efectos de los anticuerpos monoclonales dirigidos a la v\u00eda de se\u00f1alizaci\u00f3n OX40-OX40L.<\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fbloqueo-de-la-interleucina-o-inhibicion-de-ox40-l%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>En la patog\u00e9nesis de la dermatitis at\u00f3pica (DA) interviene una compleja cascada que se desarrolla a distintos niveles. Para el tratamiento de la DA de gravedad moderada a grave se&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fbloqueo-de-la-interleucina-o-inhibicion-de-ox40-l%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":563850,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Dermatitis at\u00f3pica: abordar con precisi\u00f3n las dianas inmunol\u00f3gicas","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11552,11298,11310,11475,11478],"tags":[100047,82425,84894,82424,100040,13573,100039,100042,82421,100045,65669,100043,100038,100041,100046,100044,13309],"powerkit_post_featured":[],"class_list":["post-563848","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-alergologia-e-inmunologia-clinica","category-dermatologia-y-venereologia","category-estudios","category-formacion-continua","tag-adjoin","tag-advocate-es","tag-amlitelimab-es","tag-arcadia-es","tag-bloqueo-de-la-interleucina","tag-dupilumab-es","tag-ecztra","tag-inhibicion-de-ox40-l","tag-lebrikizumab-es","tag-liberty-ad-preschool","tag-nemolizumab-es","tag-rocatinlimab","tag-rocket","tag-ruta-de-senal-ox40-ox40l","tag-stapokibart","tag-stream-ad","tag-tralokinumab-es","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-09-29 14:31:02","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/563848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=563848"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/563848\/revisions"}],"predecessor-version":[{"id":566938,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/563848\/revisions\/566938"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/563850"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=563848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=563848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=563848"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=563848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}